Mounjaro is more effective for weight loss than Ozempic—how does it work? And why does it cost so much?
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness, as well as changing how the body processes food. (In other countries, tirzepatide is also sold under the brand name Zepbound.)
Common Wegovy side effects as weight loss drug surges in popularity in the UK
Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Mounjaro, Ozempic, and Wegovy: A review of weight-loss drugs and jabs in the UK and Europe
This article delves into the pros and cons of these drugs, addressing potential side effects (including the rare ones).
All the weight loss drugs approved in the UK as doctor reveals why Ozempic isn’t
As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and reduce cravings and hunger. But in the UK, it’s only supposed to be used for type 2 diabetes, and that’s in order to try and protect the resources for the type 2 diabetics.”
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on euronews
Weight-loss drug Wegovy to hit market on Tuesday
Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order through Zeullig Pharma Korea.
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years.
Why weight-loss drugs may be no obesity silver bullet
Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given as regular injections, the treatments – Wegovy and Mounjaro – mimic a hormone that makes people less hungry.
The weight loss drug with a waitlist
Sky News has revealed thousands of people with severe obesity are being denied access to effective treatment, partly because of a slow NHS rollout of the weight loss jab Wegovy.
Best Life on MSN1h
European Countries Are Cracking Down on Weight-Loss Drugs Like Wegovy—Could the U.S. Follow?
Novo Nordisk, the pharmaceutical company behind the world’s most popular weight-loss injections, is expanding its global ...
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...
The Times of Northwest Indiana54m
Get Healthy: Drugs can jump-start weight loss, giving healthy eating, exercise habits time to work
“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...
JD Supra4d
Ozempic Weight Loss Users at Risk of Gastroparesis and Other Stomach Problems, New Study Reveals
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...
Best OTC Wegovy Alternatives: Natural Options for Effective Weight Management
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...
Don't use Ozempic or Wegovy for 'Instagram perfect body', says health secretary
Wes Streeting responded to a Sky News report which found the NHS rollout of the "game-changing" weightloss drug has been slower than planned by saying it could risk fuelling a rise in eating disorders ...